These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3818117)

  • 21. Permeability for middle and higher molecular weight substances. Comparison between polysulfone and cuprophan dialyzers.
    Brunner H; Mann H; Stiller S; Sieberth HG
    Contrib Nephrol; 1985; 46():33-42. PubMed ID: 4006479
    [No Abstract]   [Full Text] [Related]  

  • 22. Complement activation in dialysis: effects on cytokines, lymphocyte activation and beta 2 microglobulin.
    Gardinali M; Calcagno A; Conciato L; Agostoni A; Rosti A; Cori P; Vozzo N; Moroni A; Anelli A; Zoni U
    Int J Artif Organs; 1994 Jun; 17(6):337-44. PubMed ID: 7806419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers.
    Ouseph R; Hutchison CA; Ward RA
    Nephrol Dial Transplant; 2008 May; 23(5):1704-12. PubMed ID: 18156455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
    Linnenweber S; Lonnemann G
    Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
    Starzyk J; Bartelik S; Sarnecka S
    Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The next generation of dialysis membranes--barriers or pathways?
    Streicher E; Schneider H
    Contrib Nephrol; 1985; 44():127-36. PubMed ID: 3987283
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis.
    Hörl WH; Schaefer RM; Heidland A
    Am J Nephrol; 1985; 5(5):320-6. PubMed ID: 2414989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteins adsorbed on hemodialysis membranes modulate neutrophil activation.
    Kuwahara T; Markert M; Wauters JP
    Artif Organs; 1989 Oct; 13(5):427-31. PubMed ID: 2803051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hemodialysis membrane type on parathyroid hormone removal.
    Kudlac H; Fielding AM; Williams AJ
    Miner Electrolyte Metab; 1994; 20(5):245-9. PubMed ID: 7700210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two layer model for the effects of blood contact on membrane transport in artificial organs.
    Boyd RF; Langsdorf LJ; Zydney AL
    ASAIO J; 1994; 40(3):M864-9. PubMed ID: 8555636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes.
    DeSoi CA; Sahm DF; Umans JG
    Am J Kidney Dis; 1992 Oct; 20(4):354-60. PubMed ID: 1415203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous hemofiltration/hemodialysis: an effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients.
    Leber HW; Wizemann V; Goubeaud G; Rawer P; Schütterle G
    Clin Nephrol; 1978 Mar; 9(3):115-21. PubMed ID: 639371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function.
    Matzkies FK; Reinecke H; Tombach B; Kosch M; Hegger K; Milius M; Hohage H; Kisters K; Kerber S; Schaefer RM
    Am J Nephrol; 2000; 20(4):300-4. PubMed ID: 10970983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte activation during hemodialysis.
    Hörl WH; Riegel W; Steinhauer HB; Wanner C; Thaiss F; Bozkurt F; Haag M; Schollmeyer P
    Clin Nephrol; 1986; 26 Suppl 1():S30-4. PubMed ID: 3829465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS).
    Laude-Sharp M; Caroff M; Simard L; Pusineri C; Kazatchkine MD; Haeffner-Cavaillon N
    Kidney Int; 1990 Dec; 38(6):1089-94. PubMed ID: 2127434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of C5a plasma levels with different hemodialysis membranes using an enzyme-linked immunosorbent assay.
    Bingel M; Arndt W; Schulze M; Floege J; Shaldon S; Koch KM; Götze O
    Nephron; 1989; 51(3):320-4. PubMed ID: 2918943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-2-microglobulin adsorption and release in-vitro: influence of membrane material, osmolality and heparin.
    Klinke B; Röckel A; Perschel W; Abdelhamid S; Fiegel P; Walb D; Meairs S
    Int J Artif Organs; 1988 Sep; 11(5):355-60. PubMed ID: 3056863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial dialysis membranes: from concept to large scale production.
    Vienken J; Diamantoglou M; Henne W; Nederlof B
    Am J Nephrol; 1999; 19(2):355-62. PubMed ID: 10213843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
    Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
    Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
    [No Abstract]   [Full Text] [Related]  

  • 40. Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes.
    Stannat S; Bahlmann J; Kiessling D; Koch KM; Deicher H; Peter HH
    Contrib Nephrol; 1985; 46():102-8. PubMed ID: 3874042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.